{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT00801372",
      "OrgStudyIdInfo": {
        "OrgStudyId": "0522-08- HMO-CTIL"
      },
      "Organization": {
        "OrgFullName": "Hadassah Medical Organization",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells",
      "OfficialTitle": "Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 2008",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2025",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2025",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 2, 2008",
      "StudyFirstSubmitQCDate": "December 2, 2008",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 3, 2008",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 11, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 12, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Hadassah Medical Organization",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.\n\nThe major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.",
      "DetailedDescription": "The potential to reprogram somatic cells into an embryonic state raises multiple basic research questions related both to the process of reprogramming and the properties of iPS cells. We will use various approaches to study the molecular mechanisms and processes that occur during reprogramming. We will use various experimental systems to characterize and study the properties of the iPS cells, their biology, developmental potential, capability to give rise to functional differentiated progeny etc.\n\nThe clinical grade donated feeders used in this project were developed under GMP conditions using animal-free reagents. For potential future clinical applications, the iPS cells will be developed under GMP conditions, using reagents and methods that will be acceptable for clinical applications."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Pregnant, Healthy Females",
          "Healthy Male Newborns"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "termination of pregnancy",
          "surgical circumcision",
          "umbilical cord"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Case-Control"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "BioSpec": {
        "BioSpecRetention": "Samples With DNA",
        "BioSpecDescription": "Existing bank of fibroblast cells retained."
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "1",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Pre-existing Fibroblast MCB",
            "ArmGroupDescription": "Pre-existing fibroblast donors for hESC derivation project"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nhealthy, older than 18\n\nExclusion Criteria:\n\nnon healthy, younger than 18",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.\n\npregnant healthy couples older than 18 who signed an informed consent for a c-section.\n\nhealthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Benjamin E Reubinoff, MD PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "011-972-2-6774569",
            "CentralContactEMail": "benjaminr@ekmd.huji.ac.il"
          },
          {
            "CentralContactName": "Shelly E. Tannenbaum, MSQA",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "011-972-2-572-2000",
            "CentralContactEMail": "stannenbaum@hadassah.org.il"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Benjamin E Reubinoff, MD PhD",
            "OverallOfficialAffiliation": "Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hadassah Ein Kerem",
            "LocationStatus": "Recruiting",
            "LocationCity": "Jerusalem",
            "LocationZip": "9112100",
            "LocationCountry": "Israel",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Benjamin E Reubinoff, Professor",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "972-2-6776424/5",
                  "LocationContactEMail": "benr@hadassah.org.il"
                },
                {
                  "LocationContactName": "Shelly E Tannenbaum, MSQA",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "972-2-6775700",
                  "LocationContactEMail": "stannenbaum@hadassah.org.il"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "18035408",
            "ReferenceType": "background",
            "ReferenceCitation": "Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 30;131(5):861-72."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    }
  }
}